High-Purity Bortezomib Intermediate 1 (CAS 179324-87-9): Synthesis, Applications, and Advantages
Discover the critical role of Bortezomib Intermediate 1 in advancing pharmaceutical synthesis and cancer therapy development.
Get a Quote & SampleProduct Core Value
Bortezomib Intermediate 1 Trifluoroacetate
Bortezomib Intermediate 1, identified by CAS 179324-87-9, is a high-purity white powder essential for the synthesis of Bortezomib, a vital proteasome inhibitor used in cancer treatment. Its precise chemical structure (C17H29BF3NO4) and significant molecular weight (379.23) make it a valuable compound in the development of advanced pharmaceutical agents. As a key fine chemical, it serves as a critical reagent and building block for creating complex molecules, contributing to breakthroughs in drug discovery and the production of life-saving medications.
- Explore the synthesis of Bortezomib Intermediate 1 using advanced chemical methodologies to ensure maximum purity and yield.
- Understand the application of this pharmaceutical intermediate in the development of proteasome inhibitor drugs, crucial for treating conditions like multiple myeloma.
- Learn about the chemical properties, including its molecular formula C17H29BF3NO4, and its role as a versatile fine chemical for drug discovery.
- Investigate the storage conditions and handling procedures necessary to maintain the integrity of this high-quality pharmaceutical intermediate.
Key Advantages
Uncompromising Purity
With a purity of 97% minimum, this intermediate ensures reliable and reproducible results in complex pharmaceutical synthesis, supporting the development of effective cancer drugs.
Critical for Bortezomib Synthesis
Serves as a direct precursor in the synthesis of Bortezomib, a critical therapeutic agent for multiple myeloma and mantle cell lymphoma, underscoring its importance in oncology research.
Versatile Chemical Building Block
Its unique chemical structure makes it an invaluable reagent and intermediate for specialty chemicals and research, enabling innovation in medicinal chemistry.
Key Applications
Pharmaceutical Synthesis
Essential for the synthesis of APIs like Bortezomib, contributing to the development of advanced cancer therapies and research chemicals.
Drug Discovery & Development
A vital intermediate for research chemicals and reaction components, aiding in the creation of novel compounds with potential therapeutic applications.
Fine Chemical Reagent
Utilized as a versatile building block in organic synthesis, facilitating the creation of complex molecules for various advanced applications.
Oncology Drug Precursor
Specifically crucial for the production of proteasome inhibitors, playing a direct role in the manufacturing process of essential anti-cancer medications.